Molecular Therapy Methods and Clinical Development
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.0 | Q2 | 74.9% | 1.749 | Q1 | 93.9% |
| 2024 | 4.7 | Q2 | 75.4% | 1.868 | Q1 | 94.7% |
| 2023 | 4.6 | Q2 | 74.8% | 1.896 | Q1 | 95.2% |
| 2022 | 4.7 | Q2 | 71.6% | 1.825 | Q1 | 95.0% |
| 2021 | 5.8 | Q2 | 78.4% | 1.819 | Q1 | 95.2% |
| 2020 | — | — | 2.285 | Q1 | 96.4% | |
| 2019 | — | — | 1.872 | Q1 | 95.1% | |
| 2018 | — | — | 1.487 | Q1 | 91.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2329-0501
country
UScoverage
2014-2025